New Jersey is expected to receive a shipment of over 20,000 J&J vaccines next week

After pause because of rare complications, Johnson & Johnson vaccine was cleared for use

Some programs fear their vaccine supply might expire soon while others have switched to Pfizer or Moderna.

Despite recent COVID-19 vaccine pause, Johnson & Johnson earnings exceed expectations

Camden County expects to deliver 4,500 vaccinations this week, down from 16,000, due to the pause in distribution of Johnson & Johnson's COVID-19 vaccine.

Advocates have been pushing for increased visits

First tranche of more than 70,000 doses shipped to senior centers, churches and community soup kitchens

In a new deal organized by the Biden administration, Merck will help Johnson & Johnson produce millions of doses of their vaccine.

Roughly 70,000 doses are expected in New Jersey this week

Gov. Phil Murphy says New Jersey could get shipment as early as next week

Concern over relative vaccine efficacy has prompted patients' demands

Johnson & Johnson now expected to ship only ‘a few million’ doses initially

A look at the vaccines currently in use, those for which approval is being sought, and others still in trials

The company is promising 100 million doses for the U.S. by the end of June

New Brunswick-based Johnson & Johnson says its vaccine is 66% effective overall at preventing moderate and severe illness.

NJ Spotlight News roundtable: Issues with the state’s vaccination program, from equity to bottlenecks and more

Merck was late to the game in the effort to develop coronavirus vaccines and instead has been focusing on coronavirus treatments.

The vaccine wouldn't require a second dose, doesn't need hyper-cold storage

A growing list of big businesses say they are pausing political donations as the fallout from last week’s riot in Washington continues.